Wendy Levin, M.D., has been appointed vice president of Clinical Development at Fate Therapeutics and Walter Grubb has been named vice president of business development. Also, John Ferraro has been promoted to the newly created position of vice president, Clinical Operations.   Dr. Levin will head up the company’s clinical development of PROHEMA in patients with hematologic malignancies and rare genetic disorders. She joins the company from MEI Pharma, where she was vice president of Clini...